Alkaloid derivative ION-31a inhibits breast cancer metastasis and angiogenesis by targeting HSP90α
- 1 October 2021
- journal article
- research article
- Published by Elsevier in Bioorganic Chemistry
- Vol. 115, 105201
Abstract
No abstract availableKeywords
Funding Information
- Natural Science Foundation of Tianjin Municipality (17JCZDJC32900)
- National Natural Science Foundation of China (81673310)
- National Natural Science Foundation of China (81803577)
This publication has 53 references indexed in Scilit:
- Hypoxia-induced factor-1 alpha upregulates vascular endothelial growth factor C to promote lymphangiogenesis and angiogenesis in breast cancer patientsJournal of Biomedical Research, 2013
- Heat Shock Protein 90 and Role of Its Chemical Inhibitors in Treatment of Hematologic MalignanciesPharmaceuticals, 2012
- MEK genomics in development and diseaseBriefings in Functional Genomics, 2012
- Hsp90 Molecular Chaperone Inhibitors: Are We There Yet?Clinical Cancer Research, 2012
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Tumor Angiogenesis: Insights and InnovationsJournal of Oncology, 2010
- Up-regulation of PI3K/Akt signaling by 17β-estradiol through activation of estrogen receptor-α, but not estrogen receptor-β, and stimulates cell growth in breast cancer cellsBiochemical and Biophysical Research Communications, 2005
- Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and AngiogenesisJournal of Clinical Oncology, 2005
- Interaction of the PAS B Domain with HSP90 Accelerates Hypoxia-Inducible Factor-1α StabilizationCellular Physiology and Biochemistry, 2004
- The Hallmarks of CancerCell, 2000